Modulation of Aβ 16-22 aggregation by glucose.
Meenal JainAbhilash SahooSilvina MatysiakPublished in: Physical chemistry chemical physics : PCCP (2024)
The self-assembly of amyloid-beta (Aβ) peptides into fibrillar structures in the brain is a signature of Alzheimer's disease. Recent studies have reported correlations between Alzheimer's disease and type-2 diabetes. Structurally, hyperglycemia induces covalent protein crosslinkings by advanced glycation end products (AGE), which can affect the stability of Aβ oligomers. In this work, we leverage physics-based coarse-grained molecular simulations to probe alternate thermodynamic pathways that affect peptide aggregation propensities at varying concentrations of glucose molecules. Similar to previous experimental reports, our simulations show a glucose concentration-dependent increase in Aβ aggregation rates, without changes in the overall secondary structure content. We discovered that glucose molecules prefer partitioning onto the aggregate-water interface at a specific orientation, resulting in a loss of molecular rotational entropy. This effectively hastens the aggregation rates, as peptide self-assembly can reduce the available surface area for peptide-glucose interactions. This work introduces a new thermodynamic-driven pathway, beyond chemical cross-linking, that can modulate Aβ aggregation.
Keyphrases
- blood glucose
- molecular dynamics
- type diabetes
- cognitive decline
- emergency department
- high resolution
- white matter
- glycemic control
- multiple sclerosis
- insulin resistance
- single molecule
- molecular dynamics simulations
- mass spectrometry
- blood brain barrier
- weight loss
- resting state
- living cells
- functional connectivity
- binding protein